Chandan Healthcare delivered robust financial performance in the quarter ended June 2026, with consolidated net profit rising 29.53% to ₹7.50 crore compared to ₹5.79 crore in the corresponding quarter of the previous year. According to reports from Business Standard, this significant profit growth demonstrates the company's operational efficiency and market positioning during the quarter.
The company's sales revenue increased 38.32% to ₹80.85 crore in Q1 FY2026, up from ₹67.90 crore in the same quarter of the previous financial year. As reported by Business Standard, this revenue growth indicates strong demand for the company's healthcare products and services during the quarter. However, recent analysis suggests that while net sales showed strong growth, the company faces challenges with negative operating cash flow amid its aggressive expansion strategy.
Operating profit margin (OPM) improved to 24.21% in the June 2026 quarter compared to 20.44% in the corresponding quarter of the previous year. According to the financial data reported by Business Standard, this margin expansion reflects better cost management and operational efficiency during the quarter. However, recent analysis indicates that operating margins have compressed due to rising costs, which presents a challenge for the company's profitability sustainability.
Profit before depreciation and tax (PBDT) increased 21% to ₹16.16 crore from ₹13.37 crore in the previous year's corresponding quarter. As reported by Business Standard, profit before tax (PBT) grew 22% to ₹11.69 crore from ₹9.62 crore in Q1 FY2025, indicating strong operational performance across all profitability metrics. Despite these positive results, the company faces challenges with negative operating cash flow and margin sustainability amid its aggressive expansion strategy.
